Drug Profile
Osaterone
Alternative Names: Gestoxarone-acetate; Hipros; Osaterone-acetate; Prostal; TZP-4238Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator ASKA Pharmaceutical
- Class Antiandrogens; Antineoplastics; Chlorinated steroids; Pregnadienes; Small molecules
- Mechanism of Action Testosterone congener inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis; Prostate cancer
Most Recent Events
- 16 Oct 2009 Wyeth has been acquired by Pfizer
- 03 Oct 2005 Grelan Pharmaceutical has merged with Teikoku Hormone to form ASKA Pharmaceutical
- 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma